News

Pharmabiz9h
Sobi’s Gamifant receives US FDA approval for first-ever treatment for adults and children with MAS in Still's disease
Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...
PMLiVE13h
FDA approves Sobi’s Gamifant to treat severe inflammatory arthritis complication
The drug has been authorised to treat adult and paediatric patients with haemophagocytic lymphohistiocytosis (HLH)/MAS in known or suspected Still’s disease, including systemic juvenile idiopathic ...
The Pharma Letter1d
FDA approves Gamifant for HLH/MAS in Still’s disease
Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the US Food and Drug Administration ...
The Pharma Letter2d
FDA approves Gamifant for Still’s disease
Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the U.S. Food and Drug ...
Medindia2d
FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease
FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation ...
BlackDoctor2d
Juvenile Idiopathic Arthritis Symptoms | JIA Symptoms - BlackDoctor.org
Juvenile idiopathic arthritis (JIA) is inflammatory arthritis that starts in children under 16. Most forms of JIA are due to an immune system malfunction. ... Systemic JIA. This type can cause ...
BlackDoctor5d
What Are the Most Common Symptoms of Juvenile Idiopathic Arthritis? - BlackDoctor.org
Juvenile idiopathic arthritis (JIA) is inflammatory arthritis that starts in children under 16. Most forms of JIA are due to an immune system malfunction. ... Systemic JIA. This type can cause ...